SCHEMBL21865079

SCHEMBL21865079

Brc1ccc2nc(N3CCOCC3)cnc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
HRH4 Q9H3N8 3/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 5/20 0.47
HTT P42858 3/20 0.47
MAPT P10636 3/20 0.47
GAA P10253 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
PIK3CD O00329 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
MAPK1 P28482 1/20 0.44
AHR P35869 1/20 0.44
HTR3A P46098 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442764 0.94 SMN1; SMN2 (0.49) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL29414460 0.94 SMN1; SMN2 (0.49) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL13503311 0.82 HRH4 (0.51) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL9980590 0.82 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL21865082 0.82 GAA (0.59) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL3559638 0.82 MAPT (0.51) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL29142657 0.80 IRAK4 (0.44) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL21588490 0.80 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL24830044 0.80 NPC1 (0.71) SMN1; SMN2HRH4NPC1RAB9AALDH1A1
SCHEMBL31184229 0.80 NPC1 (0.71) SMN1; SMN2HRH4NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063854-A1 QUINOLINE-BASED DERIVATIVES AS VAP-1 INHIBITORS 南京明德新药研发有限公司 2020-04-02 WO disclosed